EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR USE ON LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE BPH REGISTRY

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms

Korean Journal of Andrology ◽

10.5534/kja.2011.29.2.91 ◽

2011 ◽

Vol 29 (2) ◽

pp. 91 ◽

Cited By ~ 1

Author(s):

Sang Deuk Kim ◽

Jong Kwan Park

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

The Use of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia ◽

10.1002/9781118437889.ch10 ◽

2014 ◽

pp. 113-128

Author(s):

Casey Lythgoe ◽

Kevin T. McVary

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/j.juro.2011.09.107 ◽

2012 ◽

Vol 187 (1) ◽

pp. 213-214

Author(s):

Steven A. Kaplan

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Türk Üroloji Dergisi/Turkish Journal of Urology ◽

10.5152/tud.2013.064 ◽

2013 ◽

Vol 39 (4) ◽

pp. 264-269

Author(s):

Mehmet Umul ◽

Tekin Ahmet Serel

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Urological Science ◽

10.1016/s1879-5226(10)60002-4 ◽

2010 ◽

Vol 21 (1) ◽

pp. 2-7

Author(s):

Shih-Tsung Huang

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

European Urology ◽

10.1016/j.eururo.2015.12.048 ◽

2016 ◽

Vol 70 (1) ◽

pp. 124-133 ◽

Cited By ~ 68

Author(s):

Mauro Gacci ◽

Karl-Erik Andersson ◽

Christopher Chapple ◽

Mario Maggi ◽

Vincenzo Mirone ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

BJU International ◽

10.1111/j.1464-410x.2010.09759.x ◽

2010 ◽

Vol 107 (12) ◽

pp. 1943-1947 ◽

Cited By ~ 26

Author(s):

Chen Zhao ◽

Suhn Hee Kim ◽

Sung Won Lee ◽

Ju-Hong Jeon ◽

Kyung Ku Kang ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia

BJU International ◽

10.1111/j.1464-410x.2010.09204.x ◽

2010 ◽

Vol 106 (5) ◽

pp. 674-680 ◽

Cited By ~ 35

Author(s):

Nihad A.M. Tamimi ◽

Ivan Mincik ◽

Scott Haughie ◽

Janice Lamb ◽

Anna Crossland ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

European Urology ◽

10.1016/j.eururo.2012.09.006 ◽

2013 ◽

Vol 63 (3) ◽

pp. 506-516 ◽

Cited By ~ 93

Author(s):

François Giuliano ◽

Stefan Ückert ◽

Mario Maggi ◽

Lori Birder ◽

Jay Kissel ◽

...

Keyword(s):

Urinary Tract ◽

Mechanism Of Action ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

1242: Lower Urinary Tract Symptoms Severity and International Prostate Symptom Score Bother Question Correlate with Measures of Erectile and Ejaculatory Dysfunction in Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/s0022-5347(18)35387-4 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 337-337

Author(s):

Raymond C. Rosen ◽

Kevin T. McVary ◽

James Nuckolls ◽

Richard Payne ◽

Allen D. Seftel ◽

...

Keyword(s):

Urinary Tract ◽

Symptom Score ◽

International Prostate Symptom Score ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Ejaculatory Dysfunction ◽